VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,775,000 | -24.6% | 275,963 | -38.2% | 0.06% | -25.6% |
| Q2 2016 | $8,991,000 | -98.9% | 446,442 | -98.5% | 0.09% | -98.6% |
| Q1 2016 | $797,112,000 | -77.8% | 30,308,449 | -14.3% | 6.19% | -69.8% |
| Q4 2015 | $3,595,931,000 | -40.6% | 35,375,610 | +4.3% | 20.48% | -34.0% |
| Q3 2015 | $6,051,041,000 | -19.6% | 33,922,192 | +0.1% | 31.06% | -13.5% |
| Q2 2015 | $7,527,342,000 | +11.2% | 33,884,050 | -0.6% | 35.90% | +12.0% |
| Q1 2015 | $6,770,832,000 | +37.8% | 34,089,378 | -0.7% | 32.06% | +28.1% |
| Q4 2014 | $4,913,249,000 | +8.6% | 34,331,973 | -0.5% | 25.03% | +4.4% |
| Q3 2014 | $4,525,615,000 | +4.6% | 34,494,015 | +0.6% | 23.97% | +3.9% |
| Q2 2014 | $4,325,712,000 | -4.1% | 34,298,384 | +0.2% | 23.07% | -4.3% |
| Q1 2014 | $4,510,875,000 | +12.0% | 34,217,366 | -0.3% | 24.11% | +7.6% |
| Q4 2013 | $4,027,484,000 | +11.4% | 34,305,656 | -1.0% | 22.40% | +4.4% |
| Q3 2013 | $3,614,737,000 | +20.9% | 34,647,147 | -0.3% | 21.46% | +11.4% |
| Q2 2013 | $2,990,257,000 | – | 34,738,116 | – | 19.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |